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It is becoming clear that a radical change of cell identity of differentiated cells in vivo, triggered by injury or
other adversity, provides an essential route to recovery for many different mammalian tissues. This process,
which we term adaptive cellular reprogramming, promotes regeneration in one of two ways: by providing a
transient class of repair cells or by directly replacing cells lost during tissue damage. Controlling adaptive
changes in cell fate in vivo in order to promote the body’s own cell therapy, particularly by pharmacology
rather than genetics, is likely to become an increasingly active area of future work.Change in Cell Identity: An In VivoMechanism for Tissue
Repair
Experiments in the field of enforced cellular reprogramming
(experimental transdifferentiation) have clearly demonstrated
that the differentiated cell is not a fixed entity but often retains
remarkable plasticity, even when it is derived from mature tis-
sues. Starting with nuclear transfer experiments (Gurdon 1962)
and the finding that fibroblast cell lines could be converted to
muscle by expression of the transcription factor MyoD (Davis
et al., 1987), a large number of experiments using enforced
expression of transcription factors or microRNA (miRNA) have
demonstrated that striking cell type conversions involving
many different cell types can occur, provided that the right
extrinsic signals and intracellular conditions are in place (Eber-
hard and Tosh, 2008; Yamanaka and Blau 2010; Sisakhtnezhad
and Matin, 2012).
The discovery of this surprising plasticity is having a substan-
tial impact in regenerative medicine. In particular, it has been
suggested that progress in understanding the underlying molec-
ular mechanisms will make it practicable to generate a particular
cell of interest from a more readily available cell type. This could
proceed either by reprogramming a differentiated cell to pluripo-
tency followed by directed differentiation to the desired cell type
or by direct reprogramming (also referred to as lineage reprog-
ramming or transdifferentiation) of one somatic cell type to
another (Graf and Enver, 2009; Sisakhtnezhad and Matin,
2012). Thus, the idea of using enforced cell type conversions in
the culture dish to generate patient-specific cells to replace cells
that have been lost through degeneration or injury is currently a
major area of interest (Slack, 2007; Cohen and Melton, 2011;
Jopling et al., 2011; Corbett and Tosh, 2014; Weissbein et al.,
2014).
In this article, we draw attention to another important aspect of
cell plasticity, which is less recognized but likely to become a sig-
nificant focus in regenerative medicine. This is that in many and
diverse mammalian tissues, cell type conversions constitute, in
fact, an important physiological healing mechanism in vivo.
These reprogramming events are triggered by injury or adverse
conditions and share the following features: (1) they are adaptive,
promoting tissue homeostasis and ultimately the survival of the
animal; (2) they fall into two categories, either the generation ofDetransient cell states, repair cells, that are specialized to drive
the healing process, or the generation of cells to permanently
replace those lost during injury or disease; and (3) they are not
adequately described simply as activation or de-differentiation,
since adaptive reprogramming generally combines both of types
of change.
From this perspective, apparently disparate cellular reactions
to injury in different tissues can be seen to be linked by a com-
mon biological significance. A clearer recognition of this repair
response, referred to here as adaptive cellular reprogramming,
provides a focus and conceptual framework for efforts to pro-
mote and direct such cell type conversions in injured or dis-
tressed tissues. The molecular signals that control cellular
differentiation states are rapidly being identified, and adaptive
cellular reprogramming should before long become a realistic
target for clinical intervention. The viewpoint suggested here
also helps to explain why there has been evolutionary pressure
for the risky strategy of retaining extensive cellular plasticity,
since the capacity of differentiated cells to change phenotype
has a physiological role in repairing many mammalian tissues
after injury.
We will suggest that adaptive cellular reprogramming repre-
sents amajor recoverymechanism in damaged tissues, standing
beside better recognized regeneration mechanisms such as the
activation of stem or progenitor cells, or cell replacement by pro-
liferation of remaining differentiated cells (Figure 1).
Examples of Adaptive Cellular Reprogramming
In non-mammalian systems, adaptive reprogramming is strik-
ingly illustrated in the amphibian and avian eye, where injury to
the lens triggers the cells of the dorsal iris to change from pig-
mented epithelium to the transparent epithelium of the lens.
This process replaces the damaged lens (Tsonis et al., 2004). It
therefore provides a clear example of how a change of cell iden-
tity can be adaptive and meet novel needs that arise during
adverse conditions.
This remarkable cell type conversion does not occur in the
eyes of mammals. However, what is conceptually the central
feature of this process, namely an injury-induced change in cell
fate to achieve repair, does in fact take place in many, diverse
types of mammalian tissues. This is evident from a number ofvelopmental Cell 34, September 28, 2015 ª2015 Elsevier Inc. 613
Figure 1. Regenerative Responses of
Tissues to Injury and Other Adversity
Adaptive cellular reprogramming is shown on
white background, in the left-hand upper half of
the picture. The two well-established mechanisms
for the replacement of cells lost during injury are
shown on gray background, in the right-hand
lower half of the picture. The diagram does not
illustrate the inflammatory response that typically
accompanies injury.
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generation of cells that are specialized to carry out new repair
functions to meet the particular needs imposed by injury, repair
cells, while in other instances, the cell type conversion simply
provides the tissue with cell types lost during damage, as seen
in the amphibian eye. We will now survey some of the most sig-
nificant instances of this injury response (Table 1).
A compelling example of the generation of cells with repair
functions is provided by a study of skin and heart injury (Davis
et al., 2012). When these tissues are injured, TGFb and/or angio-
tensin cause p38 MAPK-dependent activation of SRF in fibro-
blasts, which transcriptionally activates the calcium channel
TRPC6. This allows calcium entry to activate calcineurin, thereby
driving the transdifferentiation of fibroblasts to myofibroblasts.
Myofibroblasts are not present in normal skin, but they are
specialized for secretion of extracellular matrix molecules and
for contractile molding of the matrix to restore tension to injured
tissue (Hinz et al., 2012), processes that are required for wound
healing. Importantly, when the conversion of fibroblasts to myo-
fibroblasts is impaired by genetic inactivation of TRPC6, skin and
heart repair is defective, showing the adaptive nature of this re-
programming or transdifferentiation event.
Another instance of an injury-induced generation of repair cells
by a change in the phenotype of existing differentiated cells
comes from studies of nerve regeneration (Jessen and Mirsky,
2005; Arthur-Farraj et al., 2012; Fontana et al., 2012; Jessen
et al., 2015). When nerves are severed, the axons distal to the
injury degenerate, thereby depriving their peripheral targets,
such as muscle, from contact with the CNS. Arthur-Farraj et al.
(2012) showed that the differentiated myelin and non-myelin
(Remak) Schwann cells, which normally surround nerve axons,
respond to axon degeneration by rapid activation of the tran-
scription factor c-Jun. This protein then acts as a global regulator
of the conversion of myelin and Remak cells to form specialized614 Developmental Cell 34, September 28, 2015 ª2015 Elsevier Inc.repair Schwann cells in the nerve distal to
the injury. These cells form regeneration
tracks, referred to as bands of Bungner,
which guide regenerating axons along
the nerve and back to their targets. The
repair (Bungner)Schwann cells also break
down inhibitors of axon regeneration
associated with myelin, both directly by
activation of myelin autophagy (Gomez-
Sanchez et al., 2015) and indirectly by
activating macrophages that they attract
to the injured nerve by secretion of cyto-
kines including CCL2/MCP1 and Il1b
(Gaudet et al., 2011). Furthermore, therepair Schwann cells express high levels of trophic factors
including GDNF, artemin, BDNF, and erythropoietin that support
the survival of regenerating neurons and promote axon growth
(Campana, 2007; Arthur-Farraj et al., 2012; Fontana et al.,
2012; Scheib and Ho¨ke, 2013; Brosius Lutz and Barres, 2014).
c-Jun directly or indirectly controls the expression of about
180 genes in the repair Schwann cells, including GDNF and arte-
min, and regulates protein levels of cell surface proteins impli-
cated in regeneration, such as p75 neurotrophin receptor and
the adhesion molecules L1, N-cadherin, and NCAM. Conditional
inactivation of c-Jun in Schwann cells severely disturbs the con-
version of myelin and non-myelin cells to functional repair cells
after injury, which results in strong impairment of regeneration
and functional recovery (Arthur-Farraj et al., 2012). Therefore,
this reprogramming event, similar to the conversion of fibro-
blasts to myofibroblasts discussed previously, is adaptive and
essential for normal healing.
In the case of Schwann cells, the conversion to repair cells is
reversible because the Bungner cells associate with the axons
that have successfully regenerated and go on to re-adopt the
phenotype of myelin and non-myelin cells (Jessen and Mirsky,
2013; Jessen et al., 2015). It is interesting that the key role of
c-Jun in the generation of repair Schwann cells is not a reflection
of the function of this transcription factor during development,
since Schwann cell development and myelination are essentially
normal even when c-Jun is inactivated. The key role of c-Jun in
Schwann cells therefore seems to be restricted to the Schwann
cell injury response.
The examples above illustrate one of the two main ways in
which fate change promotes repair, namely by the generation
of transient repair cells that are essential facilitators of healing.
The other mechanism involves direct replacement of lost cells.
This type of adaptive cellular reprogramming is strikingly illus-
trated in experiments on the endocrine a and b cells of themurine
Table 1. Examples of Adaptive Cell Reprogramming
Category of Cell
Generated Cell Type Conversions
Generation of transient
cells that promote repair
fibroblasts/ myofibroblasts
myelin/Remak Schwann cells/
repair (Bungner) Schwann cells
microglia/ ‘‘activated’’ microglia
astrocytes/ ‘‘reactive’’ astrocytes
Generation of
replacement cells
pancreatic islet a cells/ pancreatic
islet b cells
supporting cells/ hair cells
hepatocytes/ biliary epithelial cells
The table shows the main examples of adaptive cellular reprogramming
discussed in the text. They divide into the generation of one of two cell
categories: cells equipped to limit damage and/or promote repair or cells
that directly replace those lost during tissue damage. For references,
see text.
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authors used a transgenic model of diphtheria toxin-induced
cell death to achieve a near-complete and selective destruction
of the insulin-secreting b cells. They found that the pre-existing
glucagon secreting a cells responded by transdifferentiating
into b cells. This process did not appear to be accompanied by
cell proliferation but likely involved the b cell transcription factors
Pdx1 and Nkx6.1, which were upregulated and function both to
suppress glucagon and promote insulin expression (Ritz-Laser
et al., 2003; Schisler et al., 2005). Studies in zebra fish indicate
that a cells use a degree of autocrine control when they repro-
gram to b cells since the conversion requires glucagon gene
products, either glucagon itself or glucagon-related peptides
(Ye et al., 2015). Functionally, the a-to-b cell conversion com-
pensates for the loss of the diphtheria toxin-induced loss of b
cells, restoring significant glycemic control to adult mice (Thorel
et al., 2010). Prepubescent animals possess an even more effi-
cient adaptive reprogramming mechanism, but in these young
animals, the source of new b or b-like cells is d cells, not a cells
(Chera et al., 2014). Unlike that seen in adults, the conversion
mechanism requires cell division and involves downregulation
of the transcription factor FoxO1 and upregulation of Ngn3.
Particularly well-documented cases of adaptive cellular re-
programming are seen in the vestibular and cochlear epithelium
of the mammalian ear (Forge et al., 1998; Richardson and Atkin-
son, 2015). Moreover, in this instance there are already indica-
tions of how this cellular reprogramming might be promoted
pharmacologically to improve balance or hearing deficiencies.
The vestibular and cochlear epithelium contains two types of
cell, sensory hair cells and supporting cells, which show molec-
ular expression similar to glial cells (Go´mez-Casati et al., 2010
and references therein), and surround the hair cells. The hair cells
of the vestibular epithelium have a key role inmaintenance of bal-
ance. In organotypic cultures of vestibular epithelium, even from
adult mice, selective killing of hair cells induces supporting cells
to upregulate the transcription factor ATOH1. This leads to the
direct conversion of supporting cells to hair cells, without cell di-
vision, provided Notch activity, which inhibits ATOH1 expres-
sion, is inhibited (Lin et al., 2011). The molecular mechanisms
of adult hair cell formation are related to those operating in em-Debryonic development, since the development of hair cells also
requires ATOH1, and both are inhibited by Notch signaling.
An equally impressive response of supporting cells to injury is
seen in the cochlear epithelium. In this case, the hair cells are the
primary sensors of sound waves and essential for hearing.
Induced death of hair cells in neonatal mice, either in vivo or in
organotypic cultures of the cochlea, results in the direct conver-
sion of supporting cells to hair cells, apparently without the
requirement for cell division, although cell division precedes
hair cell generation in some cases. This conversion takes place
spontaneously (Bramhall et al., 2014; Cox et al., 2014). Neverthe-
less, hair cell generation is strongly enhanced when Notch
signaling is inhibited, as in vestibular hair cells (Bramhall et al.,
2014). In neonatal cochleas treated with gentamicin to induce
hair cell loss and the g-secretase inhibitor LY411575 to inhibit
Notch signaling, the generation of hair cells from supporting cells
is inhibited by inactivation of b-catenin, indicating that the trans-
differentiation process requires Wnt signaling (Bramhall et al.,
2014). Remarkably, even in adult mice, noise-induced death of
hair cells in vivo is accompanied by upregulation of ATOH1 in
supporting cells and direct conversion of supporting cells to
new hair cells, provided Notch signaling is inhibited by g-secre-
tase inhibitors (Mizutari et al., 2013). This results in partial
reversal of the noise-induced hearing loss, confirming the adap-
tive function of this reprogramming event. In terms of potential
clinical relevance, this model of adaptive cellular reprogramming
is of interest because, at least in animal models, it can be pro-
moted by pharmacological means.
Another case of cell type replacement by conversion from
differentiated neighbors can be seen in liver. In this case,
toxin-mediated tissue damage triggers the generation of new
biliary epithelial cells in vivo by reprogramming of themore abun-
dant hepatocytes (Yanger et al., 2013), an observation sup-
ported by previous cell culture experiments (Nishikawa et al.,
2005). The hepatocyte-derived biliary cells express a number
of biliary cell markers, as well as PKCz and Par6 indicating biliary
cell-like polarity. Genetic inactivation in hepatocytes of RBPJ, an
essential component of canonical Notch signaling, suppresses
the conversion of hepatocytes to biliary cells. Notch signaling
is also required for the generation of biliary epithelial cells during
development (Zong et al., 2009). Therefore, in hepatocytes, as in
the supporting cells of the ear but unlike Schwann cells, the
mechanisms of adult reprogramming are related to develop-
ment. This is just one instance of the remarkable plasticity
seen in the liver, biliary system, and pancreas (Eberhard and
Tosh, 2008).
Adaptive Cellular Reprogramming in the Brain?
The examples that we have discussed so far show how the strik-
ing plasticity of the differentiated state, a cellular property
discovered relatively recently, can have a key role in repairing
mammalian tissues after injury. Because this facility seems to
confer significant advantage when tissues are distressed, it
would not be surprising if this repair mechanism, or something
like it, is found in other organs as well. We now discuss one
important potential case, the brain.
Numerically, glial cells are the main cellular component of the
nervous system. In a previous section, we discussed the glial
cells of peripheral nerves, Schwann cells, and their conversionvelopmental Cell 34, September 28, 2015 ª2015 Elsevier Inc. 615
Developmental Cell
Perspectiveto repair cells after injury as one of the prime examples of
adaptive cellular reprogramming (Arthur-Farraj et al., 2012; Jes-
sen et al., 2015). It is therefore interesting that two of the main
glial cell types in the brain, microglia and astrocytes, also
respond to injury or disease by striking phenotypic and func-
tional changes.
Microglia are the resident immune cells in the brain. In unper-
turbed brain tissue, these cells have traditionally been referred to
as ‘‘resting.’’ It is now widely acknowledged that this is a
misnomer because these cells are not dormant or inactive but
exist in an active surveillance mode (Kettenmann et al., 2011;
Biber et al., 2014; Sierra et al., 2014). They havemultiple fine pro-
cesses, whichmove through brain tissue to dynamically scan the
environment to detect alien molecules (Nimmerjahn et al., 2005).
Their processes often contact synapses, suggesting that they
take part in synaptic interactions, as has been shown for astro-
cytes (Wake et al., 2009; Schafer et al., 2012). In line with this, mi-
croglia express receptors for a variety of neurotransmitters, and
they can secrete a range of neuroactive substances (Ketten-
mann et al., 2011). Microglia also have a role in remodeling syn-
aptic circuits both during development (Paolicelli et al., 2011;
Schafer et al., 2012) and in the adult brain, where they have
been implicated in the control of learning and memory (Tremblay
et al., 2011; Be´chade et al., 2013; Miyamoto et al., 2013; Par-
khurst et al., 2013; Sierra et al., 2014).
This microglial phenotype, characteristic of the unperturbed
CNS, is radically transformed in response to infection, trauma,
or other significant disturbance of brain homeostasis. A range
of signals is likely to take part in alertingmicroglia to changed cir-
cumstances, but a prominent part is likely to be played by ATP
and related molecules released from dead or damaged cells,
by pattern recognition receptors (PRRs), including Toll-like re-
ceptors (TLRs), which recognize pathogen-associated signals
and aberrant endogenous molecular motifs, and by Nod family
proteins that recognize intracellular bacterial products (Ketten-
mann et al., 2011; Liu et al., 2010; Koizumi et al., 2013). When
they detect disturbance, surveillance microglia take on an alter-
native phenotype or a spectrum of phenotypes that morpholog-
ically resemble that of macrophages. In this functional state,
which is likely to differ in particulars depending on the nature
and site of the insult, microglia are often migratory and prolifera-
tive and carry out a broad range of adaptive functions that help
restore homeostasis through numerous complex interactions
with other cells. This includes the mounting of rapid defense re-
sponses, involving the innate immune system, against infection
by parasites, bacteria, and viruses, the phagocytosis of patho-
gens and cellular debris, protection against neurodegenerative
diseases, e.g., prion disease, and support of neurons by secre-
tion of neurotrophic factors such as IGF (Graeber and Streit,
2010; Kettenmann et al., 2011; Kranich et al., 2010; Ueno et al.,
2013; Biber et al., 2014). This injury response is still commonly
described as ‘‘activation,’’ but this term is unfortunate because
it is now evident that it does not represent a change from an inac-
tive to an active state. Instead, microglia in the injured CNS are
reprogrammed to a state that allows them to carry our repair-
oriented functions, which potentially promote recovery.
Although the microglial response to CNS insult is generally
beneficial, a notion that also makes sense from an evolutionary
standpoint, microglia have also been implicated in adverse reac-616 Developmental Cell 34, September 28, 2015 ª2015 Elsevier Inc.tions (Biber et al., 2014). Indeed it would not be surprising if
microglial activity, like that of macrophages, has the potential
to be harmful when dysregulated or excessive. On the other
hand, it has been pointed out recently that some of the evidence
for adverse effects of microglia on neurons is problematic due to
inappropriate signaling environment in cell culture studies, the
use of neonatal cells, or the blurring of the distinction between
the action of blood-borne monocytes and/or macrophages and
resident microglia (discussed in Biber et al., 2014).
The situation with astrocyte glial cells is interestingly similar in
a number of key essentials. Likemicroglia, these cells havemajor
functions in the normal, undisturbed brain. They maintain extra-
cellular metabolite and neurotransmitter levels, provide neurons
with nutrients, regulate synapse formation and function, and help
adjust local blood flow (Bayraktar et al., 2015; Haydon and
Nedergaard, 2015).
In response to CNS insults or other disturbance, these normal
and active astrocytes convert to alternative differentiation states
in a process traditionally referred to as reactive astrocytosis. The
signaling that controls this complex set of events includes the
transcription factor Stat3, Notch, and Shh, with their involvement
and the particular features of the process varying with the type of
injury and location within the CNS (Gallo and Deneen, 2014;
Sofroniew, 2015a). Although reactive astrocytosis involves at
least some astrocytes taking on features characteristic of earlier
developmental states, namely de-differentiation (Buffo et al.,
2008; Sirko et al., 2013), this is only part of the astrocyte
response. Reactive astrocytes also take on major, new protec-
tive and repair-oriented functions not normally associated with
developing astrocytes. This includes limiting the spread of in-
flammatory cells and infection, antigen presentation, prevention
of neuronal degeneration, and restriction of tissue loss by the for-
mation of an astrocyte scar (Zhang and Barres, 2010; Robel
et al., 2011; Burda and Sofroniew, 2014; Sofroniew, 2015b).
It is clear that these defense and repair-oriented astrocyte
phenotypes that arise in response to damage are not generated
from inactive cells. Rather, what takes place both in the case
of astrocytes and microglia is that cells that actively carry out
key functions in normal brain are reprogrammed to acquire
new functions that are tailored to promote healing and repair
and to cope with conditions that arise specifically in damaged
tissue. As with microglia, the defensive response of astrocytes
has surely evolved due to its adaptive value for the organism,
although it sometimes has undesirable consequences, particu-
larly if the injury response is over-activated or occurs inappropri-
ately (Burda and Sofroniew, 2014). This is seen, for instance,
when substantial mechanical injuries to the CNS prompt reactive
astrocytes to form a barrier, glial scar, around the damaged site,
a structure that has a number of adaptive functions, at the cost of
preventing axonal regeneration (Silver and Miller, 2004).
These phenotypic conversions of microglia and astrocytes in
the injured or diseased CNS show intriguing similarities to the
cellular changes we have pointed to as adaptive cellular reprog-
ramming in other tissues.
Adaptive Reprogramming, De-Differentiation,
Activation, and Transdifferentiation
Wehave discussed several cases in which tissue stress results in
the reprogramming of a differentiated cell to a related, but
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process of this kind implies both loss and gain of phenotypes.
Loss of phenotypes, or partial de-differentiation, is seen for
instance when glucagon-secreting a cells in the pancreas up-
regulate genes that potentially suppress glucagon synthesis
as they convert to insulin-secreting b cells and when myelin
Schwann cells lose expression ofmyelin genes as they transform
to Bungner repair Schwann cells. Likewise, pigmented epithelial
cells lose their pigment as they convert to lens epithelium after
lens injury in the classical non-mammalian example of cell type
conversion. But, adaptive reprogramming involves, in addition,
alternative differentiation, or activation, namely the acquisition
of properties that are not shared by the original cell or its devel-
opmental precursors. This is exemplified by onset of insulin
secretion in the a-to-b cell conversion, by activation of trophic
factors and mechanisms for myelin clearance in the genera-
tion of repair Schwann cells, and by upregulation of crystallin
expression in amphibian lens. Adaptive cellular reprogramming
therefore involves a combination of partial de-differentiation
and activation of alternative phenotypes in individual cells.
This combination of events is also at the center of the concept
of transdifferentiation (Jopling et al., 2011). However, the
meaning of the word transdifferentiation has become more
controversial and therefore perhaps less useful than that of re-
programming, which we use here. The term transdifferentiation
was first used in 1974 (Hakim and Kafatos, 1974; Selman and
Kafatos, 1974) and was defined in 1986 as ‘‘a change in a cell
or in its progeny from one differentiated phenotype to another’’
(Okada, 1986; see also Okada, 1980). Many subsequent texts
on the subject have narrowed the concept, for instance adding
the requirement that the cellular change in question should be
permanent or irreversible and take place between cells of
different lineages (Slack and Tosh, 2001; Rizzino, 2007; Eber-
hard and Tosh, 2008; Eguizabal et al., 2013). It has been argued
that few biological phenomena that take place in vivo warrant the
term transdifferentiation when used in this narrower sense (Zhou
and Melton, 2008). Ultimately, however, usage determines
meaning. For the term transdifferentiation, the trend in current
literature is toward the original notion (Okada, 1986) without
the later restrictions (e.g., Morroni et al., 2004; Cooley et al.,
2010; Kanazawa et al., 2010; Soda et al., 2011; Virtanen and
Nuutila, 2011). But, because in current literature the term is
both found in its restricted sense and used in a broad sense
to convey a meaning similar to that frequently understood by
the terms cell type conversion or direct (or lineage) reprogram-
ming, the meaning of the word transdifferentiation has become
ambiguous.
Notable regeneration systems, such as the salamander limb,
also involve de-differentiation and re-differentiation. In this
case, limb injury triggers the formation of proliferating blas-
temal cells, which are undifferentiated but largely retain mem-
ory of their tissue of origin and go on to re-differentiate and
generate the skin, nerves, and bone of the regenerating limb.
It is still uncertain, however, whether re-differentiation of the
tissue reflects mainly the recruitment of progenitors and/or
stem cells that reside in adult tissue or whether it involves
de-differentiation and re-differentiation of individual cells. In
the latter case, it is likely to represent a straight reversal of
the preceding de-differentiation rather than alternative differen-Detiation (Kragl et al., 2009; King and Newmark, 2012; Kumar and
Brockes, 2012).
Regarding the molecular signals that control cell type conver-
sions, major insights have come from experimental transdiffer-
entiation studies in vitro. These already provide many examples
of the generation of desired cell types, with or without the gener-
ation of pluripotent intermediates, through enforced expression
of transcription factors and modifications of epigenetic regula-
tors by miRNA or chemical modulators, where the particular fac-
tors and treatment is specific to the starting cell type and the cell
type to be generated. In most cases, the approach reflects, and
is in fact often based on, knowledge of the factors that determine
cell fate in the relevant system in vivo. In the examples of adap-
tive cellular reprogramming discussed in this article, a close
concordance between in vivo and in vitro mechanisms can
also be seen. For instance, TGFb activates p38, TRPC6 expres-
sion, and myofibroblast genes in vitro as seen in fibroblast-to-
myofibroblast conversion in vivo (Davis et al., 2012; Kurahara
et al., 2015); the conversion of hepatocytes to bile duct cells
in vitro involves activation of the Notch pathway as in vivo (Nish-
ikawa et al., 2005; Yanger et al., 2013); and enforced expression
of c-Jun in cultured Schwann cells activates GDNF expression
and suppresses myelin genes as seen during the c-Jun-depen-
dent generation of repair Schwann cells from myelin cells in vivo
(Arthur-Farraj et al., 2012).
Conclusions: The Broader Context
In addition to macrophage-mediated inflammation, which lies
outside the scope of this article, damage to mammalian tissue
triggers two well-acknowledged recovery mechanisms. First,
proliferation and differentiation of stem or progenitor cells pre-
sent in the injured tissue or elsewhere. This is seen for instance
in blood, bone, skeletal muscle, skin and in the oligodendrocyte
glial lineage in the CNS (Trumpp et al., 2010; Chang and Rud-
nicki, 2014; Crawford et al., 2014; Eming et al., 2014; Raggatt
et al., 2014). Second, proliferation of the remaining differentiated
cells, either without significant de-differentiation, or accompa-
nied by de-differentiation, in which case the de-differentiated
cells proliferate and then re-differentiate to replace lost cells.
This is seen for instance among hepatocytes after liver hepatec-
tomy and after injury of the neonatal mouse heart (Porrello et al.,
2011; Riehle et al., 2011).
In this article, we discuss the emerging evidence for an addi-
tional regeneration mechanism in mammals. It is becoming clear
that a radical change of cell identity of differentiated cells pro-
vides an essential route to recovery for many different tissues.
This change typically combines loss of some differentiated fea-
tures (a de-differentiation step) with re-differentiation along an
alternative pathway (an activation-like step), allowing one cell
type, or differentiation state, to change into another. This pro-
cess, adaptive cellular reprogramming, promotes repair in one
of two ways: by providing a transient class of repair cells or by
directly replacing cells lost during tissue damage.
Learning to manipulate this mechanism would be of great
benefit. For instance, the ability to stimulate the conversion of
supportive cells to generate hair cells in the human ear would
provide the ear with its own cell replacement therapy. Similarly,
in nerve injury, the ability to maintain the repair phenotype
of Schwann cells over the long periods required for axonalvelopmental Cell 34, September 28, 2015 ª2015 Elsevier Inc. 617
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nerve repair. In addition, the ability to stimulate the generation
of new pancreatic b cells would benefit patients with Type 1
diabetes.
Promoting the body’s own cell therapy by controlling cell fate
in vivo, particularly by pharmacology rather than genetics, is
likely to become an increasingly active area of future work.
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